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An acute catecholamine discharge immediately following 
intracranial bleeding can have devastating extracranial 
eﬀ ects: the heart, lungs, ﬂ uids and electrolytes can be 
severely aﬀ ected. Hoﬀ  and colleagues report on 
pulmonary edema (PE) following subarachnoid hemor-
rhage (SAH) [1]. Th ey found a high incidence of PE, 
usually several days after the initial bleeding, and an asso-
ciation of PE with lower intra vascular volumes (compared 
with cases without PE). PE is not uncommon after SAH, 
both as an early compli cation and as a late complication.
Neurogenic PE is an acute event directly linked with an 
intracranial disaster; as such, it is often diagnosed on 
admission in cases with severe SAH [2]. PE in the days 
following SAH has been reported in association with 
triple-H therapy, which includes hypervolemia and 
induced arterial hypertension [3]. In diﬀ erent series, the 
PE incidence varied from 14 to 23% [4,5]. Increasing 
evidence is accumulating on the myocardial dysfunction 
that follows SAH, as well as other acute intracranial 
disasters. Takot subo syndrome – with typical left 
ventricular abnor malities (bulging out of the apex of the 
heart with preserved function of the base, which earned 
the syndrome its name – a kind of a pot used as octopus 
trap in Japan), ECG abnormalities and biomarker changes – 
is a typical example of how much an injured brain can 
break the heart [6]. Neurogenic in origin, left ventricular 
failure causes congestion in the pulmonary vasculature 
and PE in Takotsubo syndrome.
What is concerning in the report of Hoﬀ  and colleagues 
is that PE, often labeled in the text as neurogenic PE, has 
been diagnosed days after the initial bleeding, without 
concurrent reduction of the cardiac index and in the 
absence of volume expansion [1]. Th e clinical implica-
tions of these ﬁ ndings, as pointed out by the authors, 
would be that PE more than 4 days after SAH is not 
cardiogenic and would not be suitable for treatment with 
diuretics. It is therefore hard to reconcile the ﬁ ndings of 
this paper with current knowledge.
Perhaps the methodology and terminology used in Hoﬀ  
and colleagues’ paper require further attention. PE has 
been identiﬁ ed by clinical signs and bilateral pulmonary 
inﬁ ltrates on the chest X-ray scan, without quantitative 
measures concerning the cardiac and respiratory func-
tion at the time of PE diagnosis. It is surprising that no 
data on oxygenation, such as a simple blood gas analysis, 
are reported. Th e hemodynamic status seems better 
docu mented, since the cardiac index and the circulating 
blood volume were estimated. Th ere are two weaknesses 
in these data, however, the ﬁ rst of which is the reliance 
on a single technique without conﬁ rmation by 
independent measures. Th e second, and more relevant, 
weakness concerns the data used in this speciﬁ c analysis: 
the data do not represent the actual circulating blood 
volume and cardiac index at the time of PE. In fact, mean 
values calculated from day 1 to the day when PE 
developed have been entered in the analysis. It becomes 
almost impossible, therefore, to use these mean data for 
correctly understanding what caused PE. Interestingly, 
diuretics were used in 65% of patients with PE in the days 
before the PE diagnosis. Were they used for correcting an 
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Pulmonary edema (PE) can occur after subarachnoid 
hemorrhage and can jeopardize arterial oxygenation, 
which is essential for a suff ering brain. In some cases 
PE is evident in the emergency room, being the direct 
consequence of intracranial bleeding, which causes 
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treatment.
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excessive volume expansion, as seems likely? If that was 
the case, PE could have been cardiogenic, and/or some-
how related to ﬂ uid manage ment, without necessarily 
depending on a neurogenic cause.
Managing patients after severe SAH is challenging: on 
one hand, their brain requires normal (or even high, in 
the case of vasospasm) arterial pressure to warrant 
cerebral perfusion and prevent delayed ischemic deﬁ cits; 
on the other hand, their heart may be damaged by an 
early sympathetic discharge, causing ischemic damage, 
and does not tolerate an increased workload. PE is a 
deleterious complication that may worsen systemic and 
cerebral oxygenation, and as such needs to be quickly 
recognized and treated [7]. Th e enthusiasm for triple-H 
therapy, which carries the risk of ﬂ uid overload and an 
indiscriminate use of vasopressors, must therefore be 
tempered.
Perhaps the most important lesson to be drawn from 
this paper [1] is the need for accurate monitoring, both 
cardiovascular and respiratory, in all SAH cases. Some 
patients may simply require good clinical surveillance 
and careful ﬂ uid balance. Th e more severe cases, on the 
contrary, should be cared for by a team capable of detect-
ing early signs of heart failure, identifying the causes of 
PE and treating them, still preserving cerebral perfusion.
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